000			04507cam a2200529Ki 4500
001			9781351013154
003			FlBoTFG
005			20220724194410.0
006			m o d
007			cr cnu---unuuu
008			201211s2021 flu ob 001 0 eng
040			_aOCoLC-P _beng _erda _cOCoLC-P
020			_a9781351013154 _qelectronic book bk
020			_a1351013157 _qelectronic book bk
020			_a9781351013130 _q(electronic bk. : EPUB)
020			_a1351013130 _q(electronic bk. : EPUB)
020			_a9781351013147 _q(electronic bk. : PDF)
020			_a1351013149 _q(electronic bk. : PDF)
020			_a9781351013123 _q(electronic bk. : Mobipocket)
020			_a1351013122 _q(electronic bk. : Mobipocket)
020			_z9780815347774
020			_z0815347774
035			_a(OCoLC)1227044579
035			_a(OCoLC-P)1227044579
050		4	_aRM301.4 _b.B44 2021
072		7	_aMED _x008000 _2bisacsh
072		7	_aMED _x071000 _2bisacsh
072		7	_aTDCW _2bicssc
082	0	4	_a615.7 _223
100	1		_aBehera, Basanta Kumara, _eauthor.
245	1	0	_aBiopharmaceuticals : _bchallenges and opportunities / _cauthored by Basanta Kumara Behera.
264		1	_aBoca Raton : _bCRC Press, _c2021.
300			_a1 online resource : _billustrations
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
505	0		_aBiopharmaceutical : A New Confront -- Biopharmaceutical Production -- Transitioning from Pharmaceutical to Biopharmaceutical -- Biopharmaceutical from Animal cells -- Plant Biomolecules and Therapeutic -- Biosimilar -- Biopharmaceutical Supply Chain Management.
520			_a"This book highlights how traditional microbial process technology has been upgraded for the production of biologic drugs, and evolution of manufacturing process to meet the global market demand with quality products under the guide lines of internally recognised regulatory bodies. This piece of work also carries information on how armed with deeper understanding of life threatening disease, the biopharmaceutical companies or life sciences industries have developed royal scientific heritage of understanding by developing formal and informal partnerships with researchers in institute, universities and other R&D organisation to fulfil the promise of timely quality production with perfect safety and security. One of the most interesting aspects of this piece of work is the conceptual development of personalized medicine (or precision medicine) to get the right treatment to the right patient at the right dose at the earlier stage of development of any inherited disease. Besides this, it also high lights on the most challenging aspects of modern biopharmaceutical science focusing on the most burning topics like design and development of biologic drugs; use of diversified groups of host cells belonging from animals, plants, microbes, insects and mammals; stem cell therapy and gene therapy; supply chain management of biopharmaceuticals; and the future scope of biopharmaceutical industry development. This book is a latest resource for a wide circle of scientists, students and researchers involve in understanding and implementing the knowledge of biopharmaceutical to develop biologics for life saving drugs, and bring awareness on personalized medicines that can potentially offer patients faster diagnoses, fewer side effects and better outcomes. Features: Explains how the traditional cells culture methodology has been changed to fully continuous or partially continuous process. It explains how to design and fabricate living organs of body by 3D bioprinting technology. It focuses on how a biopharmaceutical company confront with various problems of regulatory bodies, and develop innovative biologic drugs. It narrates in detail the update information on stem cell therapy and gene therapy. It explains the development strategies and clinical significance of bio-similars and bio-betters. It high lights on supply chain management of biopharmaceuticals"--
588			_aOCLC-licensed vendor bibliographic record.
650		0	_aPharmaceutical biotechnology.
650		0	_aBiopharmaceutics.
650		7	_aMEDICAL / Biochemistry _2bisacsh
650		7	_aMEDICAL / Pharmacology _2bisacsh
856	4	0	_3Read Online _uhttps://www.taylorfrancis.com/books/9781351013154
856	4	2	_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
942			_2lcc _cEBK
999			_c17172 _d17172